A number of other analysts also recently weighed in on VTR. Credit Suisse Group initiated coverage on shares of Ventas in a research report on Wednesday, June 22nd. They set an outperform rating and a $63.00 price target for the company. Jefferies Financial Group upgraded Ventas from a hold rating to a buy rating and raised their target price for the company from $58.00 to $59.00 in a research note on Thursday, June 30th. Royal Bank of Canada lifted their price objective on shares of Ventas from $62.00 to $63.00 in a research note on Friday, May 20th. Deutsche Bank Aktiengesellschaft lowered their target price on Ventas from $67.00 to $65.00 and set a buy rating on the stock in a report on Wednesday, July 13th. Finally, KeyCorp dropped their price target on Ventas from $65.00 to $60.00 and set an overweight rating on the stock in a research note on Thursday, July 7th. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of $61.80.
Ventas Stock Up 0.9 %
NYSE:VTR traded up $0.45 during trading hours on Tuesday, hitting $52.78. The stock had a trading volume of 23,989 shares, compared to its average volume of 2,191,870. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 1.15. Ventas has a 1-year low of $45.44 and a 1-year high of $64.02. The business has a 50 day simple moving average of $52.58 and a two-hundred day simple moving average of $54.88. The company has a market cap of $21.10 billion, a PE ratio of 135.80, a price-to-earnings-growth ratio of 3.34 and a beta of 1.15.
Ventas Dividend Announcement
In related news, CEO Debra A. Cafaro sold 17,400 shares of Ventas stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $56.43, for a total transaction of $981,882.00. Following the completion of the sale, the chief executive officer now directly owns 767,960 shares of the company’s stock, valued at approximately $43,335,982.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.
Hedge Funds Weigh In On Ventas
A number of hedge funds have recently added to or reduced their stakes in VTR. Norges Bank acquired a new stake in shares of Ventas during the 4th quarter valued at $193,927,000. BlackRock Inc. lifted its stake in shares of Ventas by 9.0% in the 4th quarter. BlackRock Inc. now owns 42,415,032 shares of the real estate investment trust’s stock valued at $2,168,257,000 after purchasing an additional 3,497,527 shares during the period. JPMorgan Chase & Co. increased its position in Ventas by 16.8% in the 1st quarter. JPMorgan Chase & Co. now owns 23,208,940 shares of the real estate investment trust’s stock valued at $1,433,382,000 after buying an additional 3,334,960 shares in the last quarter. State Street Corp increased its position in Ventas by 10.5% in the 1st quarter. State Street Corp now owns 29,045,433 shares of the real estate investment trust’s stock valued at $1,806,565,000 after buying an additional 2,769,943 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in Ventas by 19.1% in the 4th quarter. Principal Financial Group Inc. now owns 16,472,347 shares of the real estate investment trust’s stock valued at $842,871,000 after buying an additional 2,647,368 shares in the last quarter. Institutional investors own 94.02% of the company’s stock.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
- Get a free copy of the StockNews.com research report on Ventas (VTR)
- Ford Stock Rallies As EV Strategy Takes Center Stage
- Should High Yield Altria Be In Your Portfolio?
- Is Keurig-Dr. Pepper A Value Worth Buying?
- C3.AI Stock is a Bargain Enterprise Artificial Intelligence Game Changer
- Two High Yield ETF That Can Substitute For Index Funds
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.